Fresenius Medical Care | FME - Beneficio Operativo

Precio De Mercado
37.74
Cambio Diario
-0.53 -1.38%
Mensual
-8.82%
Anual
-16.13%
Q1 Expectativa
36.66




Beneficio Operativo Cambio Fecha
Akzo Nobel EUR 217M 80M 2025-12
Alcon AG USD 313M 19M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Beiersdorf EUR 504M 312M 2025-12
DaVita Healthcare Partners USD 584.2M 88.6M 2025-12
Demant DKK 2.09B 224M 2025-12
E.ON EUR 1.06B 816M 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Genmab DKK 260M 199M 2025-12
Getinge SEK 1.08B 900M 2024-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 275.38M 76.74M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 437M 2025-12
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
RWE EUR 577M 310M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
SAP EUR 2.78B 1.95B 2025-12
Smith & Nephew USD 440M 50M 2025-12